Insider Buy ·Filed Jun 17, 2026

COAG

Hemab Therapeutics Holdings, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago SEC0001231919-26-000665
Insider cluster: 1 insiders, $153K total
Actionable Insight • Neutral

The buy is too small to signal material conviction. Monitor for larger insider purchases or a cluster of buys from C-suite executives before reading this as bullish. The stock's poor historical reaction to prior reports suggests caution.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
COAG ▲ +38.41% at T+60d
NEUTRAL call ✓ call won +38.41% · α vs SPY +36.51% · entry $29.24 → $40.47
Entry anchored
Jun 17, 03:59 PM ET
via exchange tick
T+1d
+8.55%
call +8.55% · α +8.86%
$31.74
settled 4mo ago
T+5d
-5.20%
call -5.20% · α -3.53%
$27.72
settled 3mo ago
T+20d
+52.29%
call +52.29% · α +51.76%
$44.53
settled 3mo ago
T+60d
+38.41%
call +38.41% · α +36.51%
$40.47
settled 18d ago

Price Chart

Loading chart...

Executive Summary

RA Capital Management, L.P., a 10% owner, purchased $153K of COAG shares on the open market at $24.89. The buy is trivial relative to the $1.2B market cap (0.013%) and carries limited signal as a standalone event.

Key Financial Metrics

Direction
buying
Total Value
$153.0K
Insiders
1

Key Facts

  • RA Capital Management, L.P. (10% owner) bought 6,100 shares at $24.89 for $153K on 2026-06-15.
  • Purchase represents ~0.013% of COAG's $1.2B market cap.
  • Single insider buy with no C-suite participation.

Financial Impact

$153K purchase, negligible relative to market cap

insider ownership

Risk Factors

  • Insider buy is immaterial relative to market cap and may be routine portfolio rebalancing.
  • Historical reports on COAG show negative average returns at T+20 and low win rate (25%).

Market Snapshot

Exchange
Nasdaq
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001231919-26-000665
13 reports for COAG
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for COAG — sortable, filterable
TypeNow
Aug 11, 2026
7w ago
8-K
BULLISH ★ 7/10
$49.87 $44.50▼ −10.77%▼ −9.71%$30.36 (−39.12%)
Jun 17, 2026
15w ago
Insider Buy
NEUTRAL ★ 2/10
$29.24 $44.53▲ +52.29%▲ +51.76%$30.36 (+3.83%)
May 21, 2026
19w ago
Press Release
NEUTRAL ★ 5/10
$26.30 $31.83▲ +21.03%▲ +20.69%$30.36 (+15.44%)
May 4, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$25.00 $27.47▲ +9.88%▲ +4.93%$30.36 (+21.44%)
Apr 30, 2026
22w ago
Press Release
NEUTRAL ★ 5/10
$34.00 $27.13▼ −20.21%▼ −25.47%$30.36 (−10.71%)
Apr 30, 2026
22w ago
3
NEUTRAL ★ 3/10
$34.00 $27.13▼ −20.21%▼ −25.47%$30.36 (−10.71%)
Apr 30, 2026
22w ago
3
NEUTRAL ★ 3/10
$34.00 $27.13▼ −20.21%▼ −25.47%$30.36 (−10.71%)
Apr 30, 2026
22w ago
3
NEUTRAL ★ 2/10
$34.00 $27.13▼ −20.21%▼ −25.47%$30.36 (−10.71%)
Apr 30, 2026
22w ago
3
NEUTRAL ★ 2/10
$34.00 $27.13▼ −20.21%▼ −25.47%$30.36 (−10.71%)
Apr 30, 2026
22w ago
3
NEUTRAL ★ 2/10
$34.00 $27.13▼ −20.21%▼ −25.47%$30.36 (−10.71%)
Showing 10 of 13

US Market Status

Market Open — Closes in 3h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access